Reports for BAXTER CORPORATION
Company Name
BAXTER CORPORATION
Totals |
||
Shortage reports |
191 |
|
| Actual shortage: | 2 (1%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 3 (2%) | |
| Resolved: | 186 (97%) | |
Discontinuation Reports |
30 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 29 (97%) | |
| Reversed: | 1 (3%) | |
Late reports |
9 (4%) |
|
Overdue reports |
1 (50%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| 5% DEXTROSE INJECTION, USP | 5G | SOLUTION | Resolved | 2019-09-20 | 2019-10-10 | 94473 |
| 5% DEXTROSE INJECTION, USP | 5G | SOLUTION | Resolved | 2019-11-05 | 2019-11-12 | 97992 |
| 5% DEXTROSE INJECTION, USP | 5G | SOLUTION | Resolved | 2020-01-17 | 2020-02-11 | 103477 |
| 5% DEXTROSE INJECTION, USP | 5G | SOLUTION | Resolved | 2020-03-10 | 2020-03-21 | 108434 |
| 5% DEXTROSE INJECTION, USP | 5G | SOLUTION | Resolved | 2020-03-12 | 2020-04-08 | 108635 |
| 5% DEXTROSE INJECTION, USP | 5G | SOLUTION | Resolved | 2021-12-06 | 2022-09-17 | 150508 |
| 5% DEXTROSE INJECTION, USP | 5G | SOLUTION | Resolved | 2021-12-06 | 2022-09-02 | 150511 |
| 5% DEXTROSE INJECTION, USP | 5G | SOLUTION | Resolved | 2021-12-06 | 2022-08-24 | 150514 |
| 5% DEXTROSE INJECTION, USP | 5G | SOLUTION | Resolved | 2022-08-03 | 2022-09-02 | 165961 |
| 5% DEXTROSE INJECTION, USP | 5G | SOLUTION | Resolved | 2022-08-03 | 2022-08-30 | 165965 |
| 5% DEXTROSE INJECTION, USP | 5G | SOLUTION | Resolved | 2022-10-05 | 2022-10-26 | 171211 |
| 5% DEXTROSE INJECTION, USP | 5G | SOLUTION | Resolved | 2022-10-05 | 2022-12-01 | 171215 |
| 5% DEXTROSE INJECTION, USP | 5G | SOLUTION | Resolved | 2023-03-15 | 2023-03-31 | 187084 |
| 5% DEXTROSE INJECTION, USP | 5G | SOLUTION | Resolved | 2023-04-12 | 2023-04-29 | 189362 |
| 5% DEXTROSE INJECTION, USP | 5G | SOLUTION | Resolved | 2023-07-06 | 2023-07-31 | 197756 |
| 5% DEXTROSE INJECTION, USP | 5G | SOLUTION | Resolved | 2023-10-11 | 2023-10-24 | 206816 |
| 0.4% LIDOCAINE HYDROCHLORIDE AND 5% DEXTROSE INJECTION | 50MG 4MG | SOLUTION | Resolved | 2019-10-04 | 2019-11-19 | 95574 |
| 0.4% LIDOCAINE HYDROCHLORIDE AND 5% DEXTROSE INJECTION | 50MG 4MG | SOLUTION | Resolved | 2019-12-19 | 2020-01-28 | 101629 |
| HEPARIN SOD AND 0.9% SOD CHLORIDE INJ | 9MG 2UNIT | SOLUTION | Resolved | 2019-10-04 | 2020-01-07 | 95570 |
| HEPARIN SOD AND 0.9% SOD CHLORIDE INJ | 9MG 2UNIT | SOLUTION | Resolved | 2020-01-28 | 2020-03-21 | 104484 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| SELECTBAG ONE (AX2525G) | 36.8G 37.3G 20.3G 36.0G 220.0G | SOLUTION | Reversed | 2020-10-07 | 2022-07-19 | 125880 |
| SELECTBAG ONE (AX275G) | 36.0G 220.0G 51.5G 29.8G 20.3G | SOLUTION | Discontinued | 2020-10-07 | 2020-12-18 | 125887 |
| SELECTBAG ONE (AX050G) | 44.1G 20.3G 36G 220G | SOLUTION | Discontinued | 2020-10-08 | 2020-11-01 | 125971 |
| POTASS CHLOR 40MEQ 5% DEX AND 0.9% SOD CHLOR | 5G 900MG 300MG | SOLUTION | Discontinued | 2020-11-26 | 2021-02-02 | 128947 |
| CLINDAMYCIN INJECTION IN 5% DEXTROSE | 300MG | SOLUTION | Discontinued | 2023-02-06 | 2023-04-02 | 183710 |
| 1.6% SODIUM CHLORDIE PROCESSING SOLUTION | 1.6G | SOLUTION SOLUTION | Discontinued | 2022-12-13 | 2023-01-01 | 178273 |
| NUTRINEAL PD4 | 57MG 71.4MG 27MG 102MG 107.1MG 448MG 64.6MG 95.1MG 5.1MG 18.4MG 538MG 85MG 51MG 59.5MG 30MG 95.5MG 51MG 139.3MG 85MG | LIQUID | Discontinued | 2019-08-12 | 2020-06-02 | 91378 |
| NUTRINEAL PD4 | 57MG 71.4MG 27MG 102MG 107.1MG 448MG 64.6MG 95.1MG 5.1MG 18.4MG 538MG 85MG 51MG 59.5MG 30MG 95.5MG 51MG 139.3MG 85MG | LIQUID | Discontinued | 2019-08-12 | 2020-06-02 | 91382 |
| NUTRINEAL PD4 | 57MG 71.4MG 27MG 102MG 107.1MG 448MG 64.6MG 95.1MG 5.1MG 18.4MG 538MG 85MG 51MG 59.5MG 30MG 95.5MG 51MG 139.3MG 85MG | LIQUID | Discontinued | 2019-08-12 | 2020-06-02 | 91385 |
| CLINOLEIC 20% | 4% 16% | EMULSION | Discontinued | 2017-04-04 | 2018-01-01 | 5289 |